Abstract
The present study describes identification of a novel lead molecule ZINC02765569 for inhibition of protein tyrosine phosphatase 1B (PTP1B) enzyme by a high-throughput virtual screening of Zinc database against catalytic domain of PTP1B employing docking algorithm Glide. The identified hit molecule ZINC02765569 was synthesized and evaluated for in vitro PTP1B enzyme inhibition, in vitro cellular glucose uptake assay, and animal models of hyperglycemia. ZINC02765569 shows promising inhibition of PTP1B enzyme at 10 μm assay, positively up-regulate the cellular glucose uptake in skeletal cell muscle myotubes and SLM/STZ hyperglycemic animal experiments. The novel hit reported here should provide a platform for the further development of its analogs as potential PTP1B enzyme inhibitors.
Similar content being viewed by others
References
Ahmad F, Li PM, Meyerovitch J, Goldstein BJ (1995) Osmotic loading of neutralizing antibodies demonstrates a role for protein-tyrosine phosphatase 1B in negative regulation of the insulin action pathway. J Biol Chem 270:20503–20508
Ahmad F, Azevedo JL, Cortright R, Dohm GL, Goldstein BJ (1997a) Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes. J Clin Invest 100:449–458
Ahmad F, Considine RV, Bauer TL, Ohannesian JP, Marco CC, Goldstein BJ (1997b) Improved sensitivity to insulin in obese subjects following weight loss is accompanied by reduced protein-tyrosine phosphatases in adipose tissue. Metab Clin Exp 46:1140–1145
Bandyopadhyay D, Kusari A, Kenner KA, Liu F, Chernoff J, Gustafson TA, Kusari J (1997) Protein-tyrosine phosphatase 1B complexes with the insulin receptor in vivo and is tyrosine-phosphorylated in the presence of insulin. J Biol Chem 272:1639–1645
Blaskovich MA, Kim HO (2002) Recent discovery and development of protein tyrosine phosphatase inhibitors. Expert Opin Ther Pat 12:871–905
Bleasdale JE, Ogg D, Palazuk BJ et al (2001) Small molecule peptidomimetics containing a novel phosphotyrosine bioisostere inhibit protein tyrosine phosphatase 1B and augment insulin action. Biochemistry 40:5642–5654
Blume JP, Hunter T (2001) Oncogenic kinase signalling. Nature 411:355–365
Boutselis IG, Yu X, Zhang ZY, Borch RF (2007) Synthesis and cell-based activity of a potent and selective protein tyrosine phosphatase 1B inhibitor prodrug. J Med Chem 50:856–864
Burke TR, Ye B, Yan X, Wang S, Jia Z, Chen L, Zhang ZY, Barford D (1996a) Small molecule interactions with protein-tyrosine phosphatase PTP1B and their use in inhibitor design. Biochemistry 35:15989–15996
Burke TR Jr, Ye B, Akamatsu M, Ford H Jr, Yan X, Kole HK, Wolf G, Shoelson SE, Roller PP (1996b) 4′-o-[2-(2-fluoromalonyl)]-l-tyrosine: a phosphotyrosyl mimic for the preparation of signal transduction inhibitory peptides. J Med Chem 39:1021–1027
Chen YT, Seto CT (2002) Divalent and trivalent alpha-ketocarboxylic acids as inhibitors of protein tyrosine phosphatases. J Med Chem 45:3946–3952
Chen H, Cong LN, Li Y, Yao ZJ, Wu L, Zhang ZY, Burke TR Jr, Quon MJ (1999) A phosphotyrosyl mimetic peptide reverses impairment of insulin-stimulated translocation of GLUT4 caused by overexpression of PTP1B in rat adipose cells. Biochemistry 38:384–389
Combs AP, Yue EW, Bower M, Ala PJ, Wayland B et al (2005) Structure-based design and discovery of protein tyrosine phosphatase inhibitors incorporating novel isothiazolidinone heterocyclic phosphotyrosine mimetics. J Med Chem 48:6544–6548
Cummings MD, DesJarlais RL, Gibbs AC, Mohan V, Jaeger EP (2005) Comparison of automated docking programs as virtual screening tools. J Med Chem 48:962–976
Doman TN, McGovern SL, Witherbee BJ, Kasten TP, Kurumbail R, Stallings WC, Connolly DT, Shoichet BK (2002) Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B. J Med Chem 45:2213–2221
Ebalunode JO, Ouyang Z, Liang J, Zheng W (2008) Novel approach to structure-based pharmacophore search using computational geometry and shape matching techniques. J Chem Inf Model 48:889–901
Elchebly M, Payette P, Michaliszyn E, Cromlish W, Colins S, Loy AL, Normandin D, Chenng A, Himms-Hagen JC, Chan C (1999) Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283:1544–1548
Evans JL, Jallal B (1999) Protein tyrosine phosphatases: their role in insulin action and potential as drug targets. Expert Opin Ther Pat 8:139–160
Floriano WB, Vaidehi N, Zamanakos G, Goddard WA (2004) HierVLS hierarchical docking protocol for virtual ligand screening of large-molecule databases. J Med Chem 47:56–71
Fu H, Park J, Pei D (2002) Peptidyl aldehydes as reversible covalent inhibitors of protein tyrosine phosphatases. Biochemistry 41:10700–10709
Goodman LS, Gilman AG (2001) The pharmacological basis of therapeutics, 10th edn. McGraw Hill Publications, New York, pp 1679–1710
Hooft van Huijsduijnen R, Sauer WH, Bombrun A, Swinnen D (2004) Prospects for inhibitors of protein tyrosine phosphatase 1B as antidiabetic drugs. J Med Chem 47:4142–4146
Hosamani KM, Shingalapur RV (2011) Synthesis of 2-mercaptobenzimidazole derivatives as potential anti-microbial and cytotoxic agents. Arch Pharm Chem Life Sci 11:311–319
Hussain M, Ahmed V, Hill B, Ahmed Z, Taylor SD (2008) A re-examination of the difluoromethylene sulfonic acid group as a phosphotyrosine mimic for PTP1B inhibition. Bioorg Med Chem 16:6764–6777
Joshi P, Tanwar O, Rambhade S, Bhaisare M, Jain D (2012) 2-D QSAR studies of steroidal natural products oleanic acid and their semisynthetic derivatives as potent protein tyrosine phosphatase 1B inhibitors. Med Chem Res 21:351–356
Kenner KA, Anyanwu E, Olefsky JM, Kusari J (1996) Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling. J Biol Chem 271:19810–19816
Klaman LD, Boss O, Peroni OD, Kim JK, Zabotny JM, Moghal N, Lubkin M, Kim YB, Sharpe AH, Stricker-Krongrad A, Shulman GI, Neel BG, Kahn BB (2000) Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol 20:5479–5489
Klip A, Guma A, Ramlal T, Bilan PJ, Lam L, Leiter LA (1992) Stimulation of hexose transport by metformin in L6 muscle cells in culture. Endocrinology 130:2535–2544
Klon AE, Glick M, Davies JW (2004) Application of machine learning to improve the results of high-throughput docking against the HIV-1 protease. J Chem Inf Comput Sci 44:2216–2224
Kumar A, Maurya RA, Srivastava AK et al (2009) Design and synthesis of 3,5-diarylisoxazole derivatives as novel class of anti-hyperglycemic and lipid lowering agents. Bioorg Med Chem 17:5285–5292
Lembertas AV, Perusse L, Chagnon YC, Fisler JS, Warden CH, Purcell-Huynh DA, Dionne FT, Gagnon J, Nadeau A, Lusis AJ, Bouchard C (1997) Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q. J Clin Invest 100:1240–1247
Liljebris C, Larsen SD, Ogg D, Palazuk BJ, Bleasdale JE (2002a) Investigation of potential bioisosteric replacements for the carboxyl groups of peptidomimetic inhibitors of protein tyrosine phosphatase 1B: identification of a tetrazole-containing inhibitor with cellular activity. J Med Chem 45:1785–1798
Liljebris C, Martinsson J, Tedenborg L, Williams M, Barker E, Duffy JES, Nygren A, James S (2002b) Synthesis and biological activity of a novel class of pyridazine analogues as non-competitive reversible inhibitors of protein tyrosine phosphatase 1B. Bioorg Med Chem 10:3197–3212
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3–26
Lund IK, Andersen HS, Iversen LF, Olsen OH, Moller KB, Pedersen AK, Ge Y, Holsworth DD, Newman MJ, Axe FU, Moller NP (2004) Structure-based design of selective and potent inhibitors of protein-tyrosine phosphatase beta. J Biol Chem 279:24226–24235
Maccari R, Paoli P, Ottana R, Jacomelli M, Ciurleo R, Manao G, Steindl T, Langer T, Vigoritaa MG, Camici G (2007) 5-Arylidine-2,4-thiazolidinedione as inhibitors of PTP 1B. Bioorg Med Chem Lett 15:5137–5149
Maestro, version 9.2 (2011) Schrödinger. LLC, New York
Malamas MS, Sredy J, Gunawan I, Mihan B, Sawicki DR, Seestaller L, Sullivan D, Flam BR (2000) New azolidinediones as inhibitors of protein tyrosine phosphatase 1B with antihyperglycemic properties. J Med Chem 43:995–1010
Martin B, Pallen CJ, Wang JH, Graves DJ (1985) Use of fluorinated tyrosine phosphates to probe the substrate specificity of the low molecular weight phosphatase activity of calcineurin. J Biol Chem 260:14932–14937
Park H, Bhattarai BR, Ham SW (2009) Structure-based virtual screening approach to identify novel classes of PTP1B inhibitors. Eur J Med Chem 44:3280–3284
Ramachandran C, Aebersold R, Tonks NK, Pot DA (1992) Sequential dephosphorylation of a multiply phosphorylated insulin receptor peptide by protein tyrosine phosphatases. Biochemistry 31:4232–4238
Rotella DP (2004) Novel “second-generation” approaches for the control of type 2 diabetes. J Med Chem 47:4111–4112
Seely BL, Staubs PA, Reichar DR, Berhanu P, Milarski KL, Saltiel AR, Kusari J, Olefsky JM (1996) Protein tyrosine phosphatase 1B interacts with the activated insulin receptor. Diabetes 45:1379–1385
Seiner DR, LaButti JN, Gates KS (2007) Kinetics and mechanism of protein tyrosine phosphatase 1B inactivation by acrolein. Chem Res Toxicol 20:1315–1320
Sell SM, Reese D (1999) Insulin-inducible changes in the relative ratio of PTP1B splice variants. Mol Genet Metab 66:189–192
Wang XY, Bergdahl K, Heijbel A, Liljebris C, Bleasdale JE (2001) Analysis of in vitro interactions of protein tyrosine phosphatase 1B with insulin receptors. Mol Cell Endocrinol 173:109–119
Wrobel J, Li Z, Sredy J, Sawicki DR, Seestaller L, Sullivan D (2000) Synthesis and PTP1B inhibition of novel 4-aryl-1-oxa-9-thiacyclopenta[b]fluorenes. Bioorg Med Chem Lett 10:1535–1538
Xin Z, Oost TK, Abad-Zapatero C, Hajduk PJ, Pei Z, Szczepankiewicz BG, Hutchins CW, Ballaron SJ, Stashko MA, Lubben T (2003) Potent, selective inhibitors of protein tyrosine phosphatase 1B. Bioorg Med Chem Lett 13:1887–1890
Zhang ZY (2001) Protein tyrosine phosphatases: prospects for therapeutics. Curr Opin Chem Biol 5:416–423
Zhang ZY (2003) Chemical and mechanistic approaches to the study of protein tyrosine phosphatases. Acc Chem Res 36:385–392
Zhang ZY, Lee SY (2003) PTP1B inhibitors as potential therapeutics in the treatment of type 2 diabetes and obesity. Expert Opin Investig Drugs 12:223–233
Zhao H, Liu G, Xin Z, Serby MD, Pei Z, Szczepankiewicz BG, Hajduk PJ, Abad-Zapatero C, Hutchins CW, Lubben TH, Ballaron SJ, Haasch DL, Kaszubska W, Rondinone CM, Trevillyan JM, Jirousek MR (2004) Isoxazole carboxylic acid as PTP 1B inhibitors. Bioorg Med Chem Lett 14:5543–5546
Zinker BA, Rondinone CM, Trevillyan JM, Gum RJ, Clampit JE, Waring JF, Xie N, Wilcox D, Jacobson P, Frost L, Kroeger PE, Reilly RM, Koterski S, Opgenorth TJ, Ulrich RG, Crosby S, Butler M, Murray SF, McKay RA, Bhanot S, Monia BP, Jirousek MR (2002) PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice. Proc Natl Acad Sci USA 99:11357–11362
Acknowledgments
The authors gratefully acknowledge Vice Chancellor, RGPV, Bhopal and Director, CDRI, Lucknow for providing research facilities. Authors PJ, GSD wishes to thank AICTE, New Delhi for a postgraduate fellowship and AKR wishes to thank CSIR, New Delhi for providing Junior Research Fellowship.
Author information
Authors and Affiliations
Corresponding author
Additional information
Prashant Joshi and Girdhar Singh Deora contributed equally to this study.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Joshi, P., Deora, G.S., Rathore, V. et al. Identification of ZINC02765569: a potent inhibitor of PTP1B by vHTS. Med Chem Res 22, 28–34 (2013). https://doi.org/10.1007/s00044-012-0007-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-012-0007-0